Kai Uwe Eckardt

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. ncbi Anemia in critical illness
    K U Eckardt
    Medizinische Klinik mit Schwerpunkt Nephrologie und Internistische Intensivmedizin, Charite, Campus Virchow Klinikum, Berlin, Federal Republic of Germany
    Wien Klin Wochenschr 113:84-9. 2001
  2. ncbi Target hemoglobin in patients with renal failure
    K U Eckardt
    Department of Nephrology and Medical Intensive Care, Charite, Campus Virchow Klinikum, Berlin, Germany
    Nephron 89:135-43; discussion 143-4. 2001
  3. ncbi The potential of erythropoietin and related strategies to stimulate erythropoiesis
    K U Eckardt
    Department of Nephrology and Medical Intensive Care, Charite, Campus Virchow Klinikum, Berlin, Germany
    Curr Opin Investig Drugs 2:1081-5. 2001
  4. ncbi Role of hypoxia in the pathogenesis of renal disease
    Kai Uwe Eckardt
    Department of Nephrology and Medical Intensive Care, Charite, Humboldt University, Berlin, Germany
    Blood Purif 21:253-7. 2003
  5. ncbi Anaemia of critical illness-- implications for understanding and treating rHuEPO resistance
    Kai Uwe Eckardt
    Department of Nephrology and Medical Intensive Care, Charite, Campus Virchow Klinikum, Berlin, Germany
    Nephrol Dial Transplant 17:48-55. 2002
  6. ncbi Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardium
    Jan Steffen Jurgensen
    Department of Nephrology and Medical Intensive Care, Campus Virchow Klinikum, Germany
    FASEB J 18:1415-7. 2004
  7. ncbi Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma
    Michael S Wiesener
    Department of Nephrology and Medical Intensive Care, Charite, Humboldt University, Berlin, Germany
    Blood 99:3562-5. 2002
  8. ncbi Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia
    Christian Rosenberger
    Department of Nephrology and Medical Intensive Care, Charite University Medicine, Berlin, Germany
    Kidney Int 67:531-42. 2005
  9. ncbi Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells
    Christina Warnecke
    Department of Nephrology and Medical Intensive Care, Virchow Clinic, Charite University Medicine, Berlin, Germany
    FASEB J 18:1462-4. 2004
  10. ncbi Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis
    Wanja Griethe
    Department of Nephrology and Medical Intensive Care, Medical Faculty of the Charite, Humboldt University, Berlin, Germany
    J Nephrol 16:728-32. 2003

Collaborators

Detail Information

Publications63

  1. ncbi Anemia in critical illness
    K U Eckardt
    Medizinische Klinik mit Schwerpunkt Nephrologie und Internistische Intensivmedizin, Charite, Campus Virchow Klinikum, Berlin, Federal Republic of Germany
    Wien Klin Wochenschr 113:84-9. 2001
    ..Rigorous strategies of blood conservation may help to avoid transfusions. Red blood cell substitutes and recombinant erythropoietin are promising treatment options that are currently under investigation...
  2. ncbi Target hemoglobin in patients with renal failure
    K U Eckardt
    Department of Nephrology and Medical Intensive Care, Charite, Campus Virchow Klinikum, Berlin, Germany
    Nephron 89:135-43; discussion 143-4. 2001
    ..Less then 10% of patients receive EPO prior to the onset of dialysis, the mean hemoglobin level at the start of dialysis is not higher than 9 g/dl and a significant proportion of patients permanently remain below 11 g/dl...
  3. ncbi The potential of erythropoietin and related strategies to stimulate erythropoiesis
    K U Eckardt
    Department of Nephrology and Medical Intensive Care, Charite, Campus Virchow Klinikum, Berlin, Germany
    Curr Opin Investig Drugs 2:1081-5. 2001
    ....
  4. ncbi Role of hypoxia in the pathogenesis of renal disease
    Kai Uwe Eckardt
    Department of Nephrology and Medical Intensive Care, Charite, Humboldt University, Berlin, Germany
    Blood Purif 21:253-7. 2003
    ..While the majority of HIF-dependent genes confer protection against hypoxia, hypoxia-inducible gene expression has been suggested to contribute also to increased interstitial matrix deposition...
  5. ncbi Anaemia of critical illness-- implications for understanding and treating rHuEPO resistance
    Kai Uwe Eckardt
    Department of Nephrology and Medical Intensive Care, Charite, Campus Virchow Klinikum, Berlin, Germany
    Nephrol Dial Transplant 17:48-55. 2002
    ....
  6. ncbi Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardium
    Jan Steffen Jurgensen
    Department of Nephrology and Medical Intensive Care, Campus Virchow Klinikum, Germany
    FASEB J 18:1415-7. 2004
    ..Cardiomyocytes and cardiac stromal cells exhibit a marked potential for a prolonged transcriptional response to ischemia mediated by HIF. The induction of HIF-1alpha and -2alpha appears to be complementary rather than solely redundant...
  7. ncbi Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma
    Michael S Wiesener
    Department of Nephrology and Medical Intensive Care, Charite, Humboldt University, Berlin, Germany
    Blood 99:3562-5. 2002
    ..This structural change, although located at distance to the HIF-binding region, was found to inhibit binding of HIF-1alpha to VHL, thus leading to accumulation of HIF, which drives EPO production...
  8. ncbi Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia
    Christian Rosenberger
    Department of Nephrology and Medical Intensive Care, Charite University Medicine, Berlin, Germany
    Kidney Int 67:531-42. 2005
    ..Hypoxia-inducible transcription factors (HIF) are recognized as master regulators of hypoxic adaptation, but little is known about their role in renal disease...
  9. ncbi Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells
    Christina Warnecke
    Department of Nephrology and Medical Intensive Care, Virchow Clinic, Charite University Medicine, Berlin, Germany
    FASEB J 18:1462-4. 2004
    ..In conclusion, we found a remarkably restricted target gene specificity of the HIFalpha subunits, which can be overcome in cells with perturbations in the pVHL/HIF system and under forced expression...
  10. ncbi Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis
    Wanja Griethe
    Department of Nephrology and Medical Intensive Care, Medical Faculty of the Charite, Humboldt University, Berlin, Germany
    J Nephrol 16:728-32. 2003
    ..Therefore, in calciphylaxis BMP-4 can play the role of a cytokine, a growth factor or a media-calcification promoter...
  11. ncbi Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease
    Jan Henrik Hörstrup
    Department of Nephrology and Medical Intensive Care, Charite, Campus Virchow Klinikum, Berlin, Germany
    Nephrol Dial Transplant 17:1005-13. 2002
    ..Elevation of collagen fragments has been demonstrated in the serum and urine of patients with renal disease, but the dynamics of renal matrix deposition remain difficult to determine...
  12. ncbi Upregulation of hypoxia-inducible factors in normal and psoriatic skin
    Christian Rosenberger
    Nephrology and Medical Intensive Care, Charite Universitatsmedizin, Virchow Campus, Berlin, Germany
    J Invest Dermatol 127:2445-52. 2007
    ..Furthermore, such a cycle may exist in psoriasis in dermal capillaries and contribute to disease progression...
  13. ncbi Acute renal failure in patients with severe sepsis and septic shock--a significant independent risk factor for mortality: results from the German Prevalence Study
    Michael Oppert
    Department of Nephrology and Medical Intensive Care, Charite Universitatsmedizin Berlin, Humboldt University, 13353 Berlin, Germany
    Nephrol Dial Transplant 23:904-9. 2008
    ..Further, it is not known whether ARF is an independent risk factor for mortality in septic patients or merely an indicator of disease severity...
  14. ncbi Inhaled nitric oxide for ARDS due to sickle cell disease
    Michael Oppert
    Department of Nephrology and Medical Intensive Care, Charite, Campus Virchow Klinikum, University Medical Center, Berlin, Germany
    Swiss Med Wkly 134:165-7. 2004
    ..ACS evolving to acute respiratory distress syndrome (ARDS) is a rare but severe complication. In ACS iNO should be considered a beneficial therapeutic option...
  15. ncbi Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis
    Jan Steffen Jurgensen
    Department of Nephrology and Medical Intensive Care, Charite, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany
    Rheumatol Int 23:204-6. 2003
    ..In spite of this syndrome's grim prognosis, the patient recovered following intensive anticoagulation and adjunct treatment with steroids and immunoglobulins...
  16. ncbi Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography
    Martin Mockel
    Department of Cardiology, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
    Nephrol Dial Transplant 23:1588-94. 2008
    ..Patients and..
  17. ncbi Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney
    Christian Rosenberger
    Department of Nephrology and Medical Intensive Care, Charite University Clinic, Berlin, Germany
    Nephrol Dial Transplant 23:3472-8. 2008
    ..Since in the IPK distal tubular damage inversely correlates with HIF activation (Rosenberger, KI, 2005), we explored the potential of PHD-I to improve morpho-functional outcome in this model...
  18. ncbi Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure
    Wanja M Bernhardt
    Department of Nephrology and Hypertension, Nikolaus Fiebiger Center for Molecular Medicine, Friedrich Alexander University Erlangen Nuremberg, Loschgestrasse, Erlangen, Germany
    J Am Soc Nephrol 17:1970-8. 2006
    ..In conclusion, the data provide proof of principle that preconditional activation of the HIF system protects against ischemic injury. Inhibiting the activity of HIF hydroxylases therefore seems to have considerable clinical perspectives...
  19. ncbi Pathogenesis of renal anemia
    Masaomi Nangaku
    Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan
    Semin Nephrol 26:261-8. 2006
    ..As with other anemias, the consequences of renal anemia are a moderate decrease in tissue oxygen tensions and counterregulatory mechanisms that maintain total oxygen consumption, including a persistent increase in cardiac output...
  20. ncbi Erythropoietin in the critically ill: what is the evidence?
    Howard L Corwin
    Nephrol Dial Transplant 20:2605-8. 2005
  21. ncbi Normalization of hemoglobin level in patients with chronic kidney disease and anemia
    Tilman B Drueke
    Inserm Unité 507 and Assistance Publique Hôpitaux de Paris, Necker Hospital, Division of Nephrology, Paris, France
    N Engl J Med 355:2071-84. 2006
    ..Whether correction of anemia in patients with stage 3 or 4 chronic kidney disease improves cardiovascular outcomes is not established...
  22. ncbi Renal replacement therapy in the treatment of acute renal failure-intermittent and continuous
    Stefan John
    Department of Nephrology and Hypertension, University of Erlangen Nuremberg, Erlangen, Germany
    Semin Dial 19:455-64. 2006
    ..Moreover, it will be discussed whether patients with sepsis and septic shock benefit from early RRT initiation, the use of increased RRT doses, and increased removal of inflammatory mediators by RRT...
  23. ncbi Renal replacement strategies in the ICU
    Stefan John
    Department of Nephrology and Hypertension, University of Erlangen Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany
    Chest 132:1379-88. 2007
    ....
  24. ncbi Hypoxia and the HIF system in kidney disease
    Masaomi Nangaku
    Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, 7 3 1 Hongo, Bunkyo ku, Tokyo, Japan
    J Mol Med (Berl) 85:1325-30. 2007
    ..Studies utilizing HIF-stimulating agents proved efficacy in various kidney disease models, suggesting that HIF activation is an ideal target of future therapeutic approaches...
  25. ncbi Evidence for sustained renal hypoxia and transient hypoxia adaptation in experimental rhabdomyolysis-induced acute kidney injury
    Christian Rosenberger
    Christian Rosenberger, Nephrology and Medical Intensive Care, Charite Universitaetsmedizin, Augustenburger Platz 1, 13353 Berlin, Germany
    Nephrol Dial Transplant 23:1135-43. 2008
    ..Indirect evidence suggests that hypoxia contributes to the pathophysiology of rhabdomyolysis-induced acute kidney injury (AKI). However, the cellular location and kinetics of hypoxia, as well as potential hypoxia adaptation are unclear...
  26. ncbi HIF activation protects from acute kidney injury
    Alexander Weidemann
    Medical Clinic 4, Department of Nephrology and Hypertension, Friedrich Alexander University Erlangen Nuremberg, Krankenhausstrasse 12, D 91054 Erlangen, Germany
    J Am Soc Nephrol 19:486-94. 2008
    ..Therefore, development of pharmacologic agents to induce renal HIF might provide a new approach to ameliorate cisplatin-induced nephrotoxicity...
  27. ncbi Comparison of the therapeutic effects of epoetin zeta and epoetin alpha in the correction of renal anaemia
    Stefan Krivoshiev
    Multidisciplinary Hospital for Active Treatment Queen Giovanna Ltd, Sofia, Bulgaria
    Curr Med Res Opin 24:1407-15. 2008
    ..To assess the therapeutic equivalence of epoetin zeta and epoetin alpha for correction of haemoglobin (Hb) concentration in patients with anaemia and chronic kidney disease (CKD) stage 5 maintained on haemodialysis...
  28. ncbi Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients
    Tilman B Drueke
    Inserm Unit 507 and Division of Nephrology, Necker Hospital, Paris, France
    Nephrol Dial Transplant 17:28-31. 2002
    ..However, overall, the importance of hyperparathyroidism appears to be minor compared with other factors such as iron deficiency or inflammation...
  29. ncbi Cellular responses to hypoxia after renal segmental infarction
    Christian Rosenberger
    Department of Nephrology and Medical Intensive Care, Charit, Humboldt University, Berlin, Germany
    Kidney Int 64:874-86. 2003
    ..CONCLUSION: Our findings illustrate a marked potential of renal tissue to respond to regional ischemia and initiate adaptive reactions, including angiogenesis...
  30. ncbi Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here?
    Francesco Locatelli
    Nephrol Dial Transplant 19:288-93. 2004
  31. ncbi Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs
    Michael S Wiesener
    Department of Nephrology and Medical Intensive Care, Charit, Humboldt University Berlin, Germany
    FASEB J 17:271-3. 2003
    ..These data indicate that HIF-2 plays an important role in the transcriptional response to hypoxia in vivo, which is not confined to the vasculature and is complementary to rather than redundant with HIF-1...
  32. ncbi Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study
    David Verhelst
    Department of Nephrology, Tenon Hospital, , and Pierre and Marie Curie University, Paris, France
    Lancet 363:1768-71. 2004
    ..INTERPRETATION: Immunosuppressive treatment accelerates recovery from erythropoietin-induced pure red cell aplasia...
  33. ncbi Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure
    Francesco Locatelli
    Nephrol Dial Transplant 19:ii1-47. 2004
  34. ncbi Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys
    Christian Rosenberger
    Department of Nephrology and Medical Intensive Care, Charit, Campus Virchow-Klinikum, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany
    J Am Soc Nephrol 13:1721-32. 2002
    ..The expression of HIF-2alpha in peritubular fibroblasts suggests a role in erythropoietin regulation...
  35. ncbi Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery
    Katia Boven
    , , 1 Place du Parvis Notre Dame, 75181 Paris cedex 4, France
    Nephrol Dial Transplant 20:iii33-40. 2005
    ..In conclusion, these data strongly suggest that leachates were the critical contributory factor in the increased incidence of antibody-mediated PRCA attributed to EPREX/ERYPO...
  36. ncbi Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation
    Michael Oppert
    Department of Nephrology and Medical Intensive Care, Charit, Campus Virchow Klinikum, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany
    Resuscitation 53:167-70. 2002
    ..PCT was elevated a median of 2 days earlier than the clinical diagnosis of VAP. Elevations in PCT can, therefore, indicate bacterial complications in cardiac arrest patients with a non-infectious acute phase response...
  37. ncbi Oxidative stress in end-stage renal disease: an emerging threat to patient outcome
    Francesco Locatelli
    Department of Nephrology and Dialysis, Azienda Ospedale di Lecco, Ospedale A Manzoni, Italy
    Nephrol Dial Transplant 18:1272-80. 2003
    ..Among emerging CVD risk factors, oxidative stress is currently being given emphasis...
  38. ncbi The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney
    Philipp Lechler
    Interdisciplinary Center for Clinical Research, Friedrich Alexander University Erlangen Nuremberg, Nuremberg, Germany
    Am J Pathol 171:1483-98. 2007
    ..Interventional strategies to inhibit survivin's function in malignancy need to be carefully (re)evaluated for renal side effects, as well as for other possible organ dysfunctions...
  39. ncbi Organ protection by hypoxia and hypoxia-inducible factors
    Wanja M Bernhardt
    Department of Nephrology and Hypertension, Friedrich Alexander University, Erlangen, Nurnberg, Germany
    Methods Enzymol 435:221-45. 2007
    ..Oxygen-independent activation of HIF is therefore a promising therapeutic strategy for the prevention of organ injury and failure...
  40. ncbi Pure red-cell aplasia due to anti-erythropoietin antibodies
    Kai-Uwe Eckardt
    Nephrol Dial Transplant 18:865-9. 2003
  41. ncbi Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition
    Debra F Higgins
    Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Clin Invest 117:3810-20. 2007
    ....
  42. ncbi European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP)
    Carmine Zoccali
    Nephrol Dial Transplant 23:2162-6. 2008
    ..The present publication reviews the arguments based on which this decision was taken...
  43. ncbi Epidermal sensing of oxygen is essential for systemic hypoxic response
    Adam T Boutin
    Molecular Biology Section, Division of Biological Sciences, UC San Diego, La Jolla, CA 92093, USA
    Cell 133:223-34. 2008
    ..These results demonstrate that in mice the skin is a critical mediator of systemic responses to environmental oxygen...
  44. ncbi Managing a fateful alliance: anaemia and cardiovascular outcomes
    Kai Uwe Eckardt
    Department of Nephrology and Hypertension, University of Erlangen Nurember, Germany
    Nephrol Dial Transplant 20:vi16-20. 2005
    ..The Cardiovascular risk Reduction by Early Anaemia Treatment with Epoetin beta (CREATE) study is investigating whether this approach is associated with a measurable reduction in cardiovascular risk...
  45. ncbi Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins
    Gertrud Weber
    Department of NephrologyAlfried Krupp Hospital, Essen, Germany
    J Am Soc Nephrol 13:2381-3. 2002
    ..Anti-EPO antibodies crossreactive with epoetin-beta and darbepoetin-alpha were demonstrated in patient serum. PRCA gradually improved after treatment with prednisolone...
  46. ncbi The specific contribution of hypoxia-inducible factor-2alpha to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors
    Christina Warnecke
    Department of Nephrology and Hypertension, University Clinic Erlangen, Germany
    Exp Cell Res 314:2016-27. 2008
    ..Thus, HIF-2alpha effects are modulated by a number of intrinsic and extrinsic factors which may be most relevant in tumour cells...
  47. ncbi Erythropoietin receptors: their role beyond erythropoiesis
    Jerome Rossert
    Nephrol Dial Transplant 20:1025-8. 2005
  48. ncbi Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction
    Alexander Weidemann
    Department of Nephrology and Hypertension, University of Erlangen Nuremberg, Krankenhausstr 12, 91054 Erlangen, Germany
    Biochem J 409:233-42. 2008
    ..Induction of BNP may therefore contribute to the potential benefits of pharmacological HIF inducers in the treatment of ischaemic heart disease and heart failure...
  49. ncbi Appraisal of evidence and control of bias in the kidney disease outcomes quality initiative guideline development process
    David Van Wyck
    Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona 85719, USA
    Clin J Am Soc Nephrol 2:8-10. 2007
  50. ncbi A new initiative in nephrology: 'Kidney disease: improving global outcomes'
    Norbert Lameire
    Renal Division, University Hospital of Ghent, Ghent, Belgium
    Contrib Nephrol 149:90-9. 2005
    ....
  51. ncbi Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    Andrew S Levey
    Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Kidney Int 67:2089-100. 2005
    ..Kidney disease treatment by dialysis and transplantation should be noted. Simple, uniform classifications of CKD by cause and by risks for kidney disease progression and CVD should be developed...
  52. ncbi Inconsistent effects of acidosis on HIF-alpha protein and its target genes
    Carsten Willam
    Department of Nephrology and Hypertension, Medizinische Klinik IV, University of Erlangen Nuremberg, Germany
    Pflugers Arch 451:534-43. 2006
    ....
  53. ncbi The burden of kidney disease: improving global outcomes
    Garabed Eknoyan
    Baylor College of Medicine, Houston, Texas 77030, USA
    Kidney Int 66:1310-4. 2004
    ..Its stated mission is "Improve the care and outcomes of kidney disease patients worldwide through promoting coordination, collaboration and integration of initiatives to develop and implement clinical practice guidelines."..
  54. ncbi Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock
    Michael Oppert
    Department of Nephrology and Medical Intensive Care, , Humboldt University, Berlin, Germany
    Crit Care Med 33:2457-64. 2005
    ..Hemodynamic improvement seemed to be related to endogenous cortisol levels, whereas immune effects appeared to be independent of adrenal reserve...
  55. ncbi HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation
    Carsten Willam
    Henry Wellcome Building for Molecular Physiology, Oxford, UK
    J Mol Cell Cardiol 41:68-77. 2006
    ..Inducibility of PHD2 and 3 by hypoxia and ischemia in vivo has important implications both for the pathophysiology of conditions where oxygen supply is deranged and for attempts to manipulate the HIF system therapeutically...
  56. ncbi Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia
    Iain C Macdougall
    Department of Renal Medicine, King s College Hospital, London SE5 9RS, UK
    Lancet 368:947-53. 2006
    ..We review these new therapeutic strategies, and discuss at what stage some of the newer products are in relation to their clinical development programme...
  57. ncbi Anti-erythropoietin antibodies and pure red cell aplasia
    Jerome Rossert
    Department of Nephrology, Tenon hospital and Pierre and Marie Curie University, Paris, France
    J Am Soc Nephrol 15:398-406. 2004
  58. ncbi Immunohistochemical detection of hypoxia-inducible factor-1alpha in human renal allograft biopsies
    Christian Rosenberger
    Nephrology and Medical Intensive Care, Charite Universitatsmedizin, Virchow Campus, Augustenburger Platz 1, 13353 Berlin, Germany
    J Am Soc Nephrol 18:343-51. 2007
    ....
  59. ncbi Mobilization of osmotically inactive Na+ by growth and by dietary salt restriction in rats
    Markus Schafflhuber
    Department of Nephrology and Hypertension, Friedrich Alexander University, Erlangen, Nurnberg, Germany
    Am J Physiol Renal Physiol 292:F1490-500. 2007
    ....
  60. ncbi The importance of diabetic nephropathy in current nephrological practice
    Francesco Locatelli
    Department of Nephrology and Dialysis, Azienda Ospedale di Lecco, Ospedale A Manzoni, Lecco, Italy
    Nephrol Dial Transplant 18:1716-25. 2003
    ..Diabetic nephropathy has become the major cause of end-stage renal disease (ESRD) in the western world and is forecast to become the most frequent cause of ESRD in the African continent and in developing countries in other areas...
  61. ncbi Hypoxia-inducible transcription factors and their role in renal disease
    Kai Uwe Eckardt
    Department of Nephrology and Hypertension, University of Erlangen Nuernberg, Erlangen, Germany
    Semin Nephrol 27:363-72. 2007
    ..On the other hand, continuous activation of the HIF system occurs in kidney cancer and potentially promotes tumor growth. HIF therefore also is explored as a target for anticancer therapy...
  62. ncbi Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia
    Michael S Wiesener
    Interdisciplinary Centre for Clinical Research IZKF, Friedrich Alexander University of Erlangen Nuremburg, Erlangen, Germany
    Int J Cancer 121:2434-42. 2007
    ..Further to the reported expression of EPO receptors in tumour tissues, the finding of widespread expression of EPO in RCC supports the recent notion of an involvement of this system in paracrine or autocrine effects of tumour cells...
  63. ncbi Latest US KDOQI Anaemia Guidelines update--what are the implications for Europe?
    Iain C Macdougall
    Nephrol Dial Transplant 22:2738-42. 2007